At a glance
Which R73.0 code do I assign?
The R73.0 subcategory splits on which glucose abnormality the provider names in the note. R73.03 belongs only where the documentation states prediabetes as the clinical diagnosis.
Tabular notes
Operational & financial impact
Why specificity matters beyond the chart: risk adjustment, DRG assignment and denial exposure all follow from which code is selected.
Documentation checklist to support R73.03
Chart elements that support code selection and reduce specificity-driven denials.
FAQ
Yes. R73.03 is a valid billable code for HIPAA covered transactions. It is valid in the FY2026 code set and unchanged in the FY2027 update.
R73.03 and a type 2 diabetes code are not reported together for the same condition. Category R73 and subcategory R73.0 each carry an Excludes1 note for diabetes mellitus (E08–E13). Once the provider establishes diabetes mellitus, the E code applies and R73.03 is no longer appropriate for that condition. Never report R73.03 and E11.9 for the same condition in the same patient.
R73.03 applies when the provider documents prediabetes as the diagnosis. R73.01 applies to a documented impaired fasting glucose finding. R73.02 applies to a documented impaired glucose tolerance finding on oral testing. The label the clinician uses in the note governs the selection.
No. R73.03 maps to no HCC category under CMS-HCC v28. It carried no HCC category under v24 either. Prediabetes documentation alone does not affect a Medicare Advantage risk score. Confirmed diabetes coded to E08, E10, E11 or E13 carries HCC weight in v28. The exceptions are the newer codes E10.A0–E10.A2 and E11.A, which postdate the v28 mapping file and have no confirmed v28 status. The E09 drug or chemical induced diabetes codes are absent from the v28 crosswalk.
An HbA1c of 6.0 percent supports R73.03 only when the provider has documented prediabetes as a clinical conclusion in the note. The laboratory result alone does not determine code selection. The clinician's documented diagnosis governs.
The encounter moves to E11.9, or to the E11 combination code that matches the complications documented. R73.03 is no longer reported for that condition. E11.9 maps to HCC 38, Diabetes with Glycemic, Unspecified, or No Complications, under CMS-HCC v28, which R73.03 does not.
In the outpatient setting R73.03 is reported for ongoing prediabetes monitoring when the provider documents prediabetes. Code the documented condition. Do not report the underlying laboratory findings separately. On the inpatient side, when another condition occasions the admission, prediabetes is reported as a secondary diagnosis alongside it.
R73.03 is unchanged in the FY2027 update, effective 1 October 2026. The FY2027 addenda make no change in category R73. At category R79, hyperglycemia NOS (R73.9) moved from the Excludes1 note to the Excludes2 note.
Related codes
Codes in the same family as R73.03. Only codes with a published page render as links.
Sibling codes in the R73.0 family
- R73.01: Impaired fasting glucose.
- R73.02: Impaired glucose tolerance (oral).
- R73.09: Other abnormal glucose.
Additional codes to consider
Codes outside the R73.0 family considered alongside R73.03.
Consider instead
- E11.9: Type 2 diabetes mellitus without complications. Use once the provider establishes type 2 diabetes.
- E10.9: Type 1 diabetes mellitus without complications. Use once the provider establishes type 1 diabetes.
- E08.9: Diabetes mellitus due to underlying condition without complications. Use when the diabetes is attributed to an underlying condition.
- E09.9: Drug or chemical induced diabetes mellitus without complications. Use when a drug or chemical is documented as the cause.
- E13.9: Other specified diabetes mellitus without complications. Use for a specified type that fits none of the other diabetes categories.
- R73.9: Hyperglycemia, unspecified. Use for elevated glucose the provider has not classified.
- E88.81-: Metabolic syndrome and other insulin resistance. Use when dysmetabolic syndrome X is documented.
- R81: Glycosuria. Use for glucose in the urine, which is a distinct finding from elevated plasma glucose.
- E16.2: Hypoglycemia, unspecified. Use for low blood glucose.
- E10.A-: Type 1 diabetes mellitus, presymptomatic. Use when presymptomatic stage 1 or stage 2 type 1 diabetes is documented.
- O99.81-: Abnormal glucose complicating pregnancy, childbirth and the puerperium. Use for a glucose finding during pregnancy.
- O24.4-: Gestational diabetes mellitus. Use when gestational diabetes is documented.
Sources
All claims on this page derive from government and professional-standards sources.
- National Center for Health Statistics. (2026). International classification of diseases, tenth revision, clinical modification (ICD-10-CM) FY2027 files. https://www.cdc.gov/nchs/icd/icd-10-cm/files.html
- Centers for Medicare & Medicaid Services and National Center for Health Statistics. (2026). ICD-10-CM official guidelines for coding and reporting FY2027. https://ftp.cdc.gov/pub/Health_Statistics/NCHS/Publications/ICD10CM/2027/ICD-10-CM-October-1-2026-FY27-Guidelines.pdf
- Centers for Medicare & Medicaid Services. (2025). 2026 model software/ICD-10 mappings. https://www.cms.gov/medicare/payment/medicare-advantage-rates-statistics/risk-adjustment/2026-model-software-icd-10-mappings
- Centers for Medicare & Medicaid Services. (2026). MS-DRG classifications and software, version 44. https://www.cms.gov/medicare/payment/prospective-payment-systems/acute-inpatient-pps/ms-drg-classifications-and-software
